Skip to content

Released May 7, 2018, before the open

10-Q filed May 7, 2018, 37 days after period end · 0001144204-18-025522

Q1 2018 · 10-Q
Revenue$428.03K— vs Q1 2017no prior Q4 2017 on file
Net Income-$2.72MN/M vs Q1 2017N/M vs Q4 2017
EPS Diluted-$0.13N/M vs Q1 2017N/M vs Q4 2017
Operating Income-$2,636,986N/M
Operating Cash Flow-$3,746,211N/M
Margins · derived
Operating margin-616.1%
Net margin-635.5%

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ1 2018Q1 2017Q1 2016Q1 2015
Revenue$428.03K$0.00——
Net Income-$2.72M-$4.86M-$7.01M-$2.96M
EPS Diluted-$0.13-$0.26-$0.38-$0.23

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR